This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/SNDX/capital-change-brief"
Use Arkolith's capital_change_brief for SNDX. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | $192.8M | 8.3M | ▲+0.2% Added · +15K sh | Q1 2026 | |
| 2 | Kynam Capital Management, LP | $188.1M | 8.1M | —Held | Q1 2026 | |
| 3 | GOLDMAN SACHS GROUP INC | $116.7M | 5.0M | ▼−12% Reduced · −699K sh | Q1 2026 | |
| 4 | STATE STREET CORP | $103.5M | 4.4M | ▼−3.6% Reduced · −166K sh | Q1 2026 | |
| 5 | BANK OF AMERICA CORP /DE/ | $99.3M | 4.2M | ▼−9.8% Reduced · −461K sh | Q1 2026 | |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $89.3M | 3.8M | ▲New +3.8M sh | Q1 2026 | |
| 7 | DEERFIELD MANAGEMENT COMPANY, L.P. | $88.3M | 3.8M | ▲New +3.8M sh | Q1 2026 | |
| 8 | Eversept Partners, LP | $67.4M | 2.9M | ▼−13% Reduced · −429K sh | Q1 2026 | |
| 9 | KINGDON CAPITAL MANAGEMENT, L.L.C. | $58.4M | 2.5M | ▲+6.4% Added · +150K sh | Q1 2026 | |
| 10 | Hood River Capital Management LLC | $55.0M | 2.4M | ▲+1.6% Added · +38K sh | Q1 2026 | |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | $50.4M | 2.2M | ▲+3.2% Added · +66K sh | Q1 2026 | |
| 12 | FRANKLIN RESOURCES INC | $50.2M | 2.2M | ▼−11% Reduced · −272K sh | Q1 2026 | |
| 13 | Point72 Asset Management, L.P. | $46.4M | 2.0M | ▼−59% Reduced · −2.9M sh | Q1 2026 | |
| 14 | VANGUARD PORTFOLIO MANAGEMENT LLC | $40.6M | 1.7M | ▲New +1.7M sh | Q1 2026 | |
| 15 | BNP Paribas Asset Management Holding S.A. | $40.5M | 1.7M | ▲+26% Added · +357K sh | Q1 2026 | |
| 16 | Soleus Capital Management, L.P. | $40.3M | 1.7M | ▼−23% Reduced · −520K sh | Q1 2026 | |
| 17 | D. E. Shaw & Co., Inc. | $37.4M | 1.6M | ▲+31% Added · +382K sh | Q1 2026 | |
| 18 | TWO SIGMA INVESTMENTS, LP | $36.9M | 1.6M | ▲+38% Added · +433K sh | Q1 2026 | |
| 19 | Nuveen, LLC | $34.9M | 1.5M | ▲+0.8% Added · +12K sh | Q1 2026 | |
| 20 | MPM BioImpact LLC | $31.3M | 1.3M | ▲+0.2% Added · +3K sh | Q1 2026 | |
| 21 | Woodline Partners LP | $29.2M | 1.3M | ▲~0% Added · +92 sh | Q1 2026 | |
| 22 | STEMPOINT CAPITAL LP | $28.4M | 1.2M | ▼−9.2% Reduced · −124K sh | Q1 2026 | |
| 23 | UBS Group AG | $26.9M | 1.2M | ▲+61% Added · +437K sh | Q1 2026 | |
| 24 | Catalio Capital Management, LP | $24.4M | 1.0M | ▼−13% Reduced · −153K sh | Q1 2026 | |
| 25 | Bank of New York Mellon Corp | $23.5M | 1.0M | ▼−8.2% Reduced · −90K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | Metzger Michael A | Chief Executive Officer, Director | Option exercise (M) | 32K | $207K |
| Jul 8, 2026 | Metzger Michael A | Chief Executive Officer, Director | Sell (S) | 32K | $785K |
| Jul 8, 2026 | Metzger Michael A | Chief Executive Officer, Director | Option exercise (M) | 32K | $0 |
| Jun 12, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | Option exercise (M) | 31K | $432K |
| Jun 12, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | Sell (S) | 31K | $567K |
| Jun 12, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | Option exercise (M) | 31K | $0 |
| Jun 11, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | Option exercise (M) | 23K | $311K |
| Jun 11, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | Sell (S) | 34K | $617K |
| Jun 11, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | Option exercise (M) | 23K | $0 |
| Jun 1, 2026 | Goldan Keith A. | Chief Financial Officer | Sell (S) | 1K | $22K |
| Jun 1, 2026 | Metzger Michael A | Chief Executive Officer, Director | Sell (S) | 7K | $130K |
| Feb 9, 2026 | Goldan Keith A. | Chief Financial Officer | Sell (S) | 3K | $72K |
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 72 funds | $9.0B |
| BOSTON SCIENTIFIC CORPBSX | 72 funds | $2.4B |
| INTUITIVE SURGICAL INCISRG | 71 funds | $2.9B |
| GILEAD SCIENCES INCGILD | 69 funds | $2.8B |
| STRYKER CORPSYK | 69 funds | $1.3B |
| MICRON TECHNOLOGY INCMU | 68 funds | $8.2B |
| NEUROCRINE BIOSCIENCES INCNBIX | 68 funds | $722.3M |
| MICROSOFT CORPMSFT | 67 funds | $32.6B |
| BROADCOM INCAVGO | 67 funds | $19.1B |
| COSTCO WHOLESALE CORPCOST | 67 funds | $5.7B |
| PALANTIR TECHNOLOGIES INC-APLTR | 67 funds | $5.2B |
| LAM RESEARCH CORPLRCX | 67 funds | $4.4B |
Ranked by how many of SNDX's institutional holders also hold each name, a cross-fund conviction signal. Via the MCP server (ticker.co_held).
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for SNDX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.